![Namandje Bumpus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 458 199 $ am 31.05.2026
Namandje N.
Bumpus is an Independent Director at Recursion Pharmaceuticals, Inc. since 2025.
Dr. Bumpus is Senior VP, Chief Innovation & Scientific Officer at Charles River Laboratories International, Inc. since 2026.
Dr. Bumpus is a Venture Partner at F-Prime Inc. since 2025.
Formerly, Dr. Bumpus was a Director at AI Proteins, Inc. Dr. Bumpus was a Professor at The Johns Hopkins University School of Medicine from 2020 to 2022.
Dr. Bumpus completed undergraduate studies at Occidental College in 2003 and earned a doctorate from the University of Michigan in 2007.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.06.2026 | 127’632 ( 0.02% ) | 458 199 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.03.2025 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.01.2026 |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private Equity Investor | 01.05.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2022 |
AI Proteins, Inc.
 AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Charles River Laboratories International, Inc.
 Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
AI Proteins, Inc.
AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
